Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies
In recent decades, improvements in breast cancer management have increased overall patient survival; however, many cancer therapies have been linked to an important risk of cardiovascular adverse events. Cardio-oncology has been proposed as an emerging specialty to coordinate preventive strategies t...
Main Authors: | Ana Aurora Díaz-Gavela, Lourdes Figueiras-Graillet, Ángel Montero Luis, Juliana Salas Segura, Raquel Ciérvide, Elia del Cerro Peñalver, Felipe Couñago, Meritxell Arenas, Teresa López-Fernández |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/7/1712 |
Similar Items
-
Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01) -
Pericardial disease after breast cancer radiotherapy
by: Marinko Tanja
Published: (2018-09-01) -
The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
by: Inbar Nardi Agmon, et al.
Published: (2022-02-01) -
The broad spectrum of cardiotoxicities from immunotherapies
by: Martina Iengo, et al.
Published: (2023-09-01) -
Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
by: Dong-Woo Kang, et al.
Published: (2022-01-01)